Colchicine May Prevent Liver Cancer in Viral Hepatitis Patients
Filed in archive Drugs, Vaccines and Therapeutics by ruth on September 11, 2006
of the liver due to viral disease, 116 were treated with colchicine.They found that only about one in ten (9 percent) of patients treated with colchicine developed HCC compared to more than one in four (29 percent) of untreated cirrhotic patients. In addition, if subjects developed HCC, patients who were treated with colchicine developed HCC later than those not treated with the drug. Colchicine chemoprevention delayed the diagnosis of HCC after cirrhosis onset by an average 72 months (222 months compared to 150 months). Furthermore, colchicine-treated patients survived longer than untreated patients.
Source: John Wiley & Sons, Inc. Newsroom
Permalink: Colchicine May Prevent Liver Cancer in Viral Hepatitis Patients
Tags:
cancer liver biotech patients colchicine liver+cancer prevent+liver colchicine+prevent
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/35980






